| HOME >> BIOLOGY >> TECHNOLOGY |
SHANGHAI, China, Dec. 5 /PRNewswire/ -- Representatives from over 40 Shanghai area hospitals, more than double the expected attendance, took part in the first annual Cinpathogen Hematology Conference at Shanghai's Equatorial Hotel. The conference, hosted by Cinpathogen Inc. and chaired by Professor Lin Guowei, Director of the Shanghai Clinical Epidemiology Institute, covered current developments in clinical laboratory medicine and shared valuable findings from the Shanghai Health Study.
"The level of interest in the conference was far beyond what we expected," said Dr. Richard Irons, Laboratory Director and Cinpathogen CEO. "It demonstrates the growing demand for high-quality healthcare delivery and research in China."
The event included presentations by Western and Chinese hematologists and pathologists on recent developments and research findings in the field of clinical diagnosis, hematology, toxicology, and pathology. The research presented was the result of the Shanghai Health Study, a 5-year-long clinical study of Chinese patients with hematopoietic disease, led by Cinpathogen Inc. through its partnership with Fudan University and the extensive cooperation of leading hospitals in Shanghai. Cinpathogen's well-established research relationships have allowed company doctors and scientists to diagnose, collect and characterize over 2000 cases of hematopoietic and lymphoid disease over the last 4 years, resulting in a dozen peer-reviewed publications and one of the world's largest tissue banks dedicated to diseases of the blood and immune system.
Professor Ouyang Renrong, former chairman of both the Chinese
Hematology Society and the Shanghai Hematology Society, applauded the
accomplishment. "The Shanghai Health Study is one-of-its-kind in China and
probably in the world. It is strong evidence of how science can make
outstanding contributions to society through an integrated, big sampling
approach. Had each hospital in Shanghai focused o
'/>"/>
| SOURCE Cinpathogen Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
2. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
3. Doping technique brings nanomechanical devices into the semiconductor world
4. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
5. The Food Allergy & Anaphylaxis Network (FAAN) and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies
6. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
7. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
8. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
9. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
10. American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest
11. Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against Superbugs
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |